9W Capital Management
2
25M
1
0.50
1
- Areas of investment
Summary
Among the most popular portfolio startups of the fund, we may highlight Kezar Life Sciences. We can highlight the next thriving fund investment areas, such as Life Science, Therapeutics.
The standard case for the fund is to invest in rounds with 6 partakers. The meaningful sponsors for the fund in investment in the same round are Omega Funds, Morningside Group, EcoR1 Capital. In the next rounds fund is usually obtained by Qiming Venture Partners, Pappas Ventures, Omega Funds.
The increased amount of exits for fund were in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2015. The fund is generally included in less than 2 deals every year.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 1
- Follow on index
- 0.50
- Investments by industry
- Life Science (2)
- Health Diagnostics (2)
- Therapeutics (2)
- Health Care (2)
- Investments by region
-
- United States (2)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Kezar Life Sciences | 05 Jun 2015 | Health Care, Health Diagnostics, Life Science, Therapeutics | Early Stage Venture | 23M | United States, California, South San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.